Infectious Complications after Prostate Biopsy: A Prospective Multicenter Prostate Biopsy Study
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Purpose: Recent studies have highlighted an increasing trend of infectious complications due to fluoroquinolone-resistant organisms among men undergoing transrectal prostate biopsy. This study evaluated the current incidence of infective complications after trans-rectal prostate biopsy for identification of risk factors in Korean men who received fluoroquinolone prophylaxis.Materials and Methods: A prospective, multicenter study was conducted in Korea from January to December 2015. Prostate biopsies performed with fluoroqui-nolone prophylaxis during 3 months in each center were included. A pre-biopsy questionnaire was used for identification of patient characteristics. Clinical variables including underlying disease, antibiotic prophylaxis, enema, povidone- iodine cleansing of the rectum, and infectious complications were evaluated. The primary outcome was the post-biopsy infection rate after fluoroquinolone prophylaxis. Univariable and multivariable analyses were used for identification of risk factors for infectious complications.Results: The study included 827 patients, of whom 93 patients (11.2%) reported receiving antibiotics in the previous 6 months and 2.5% had a history of prostatitis. The infectious complication rate was 2.2%. Post-biopsy sepsis was reported in 2 patients (0.2%). In multivariable analysis predictors of post-biopsy sepsis included person performing biopsy (adjusted odds ratio [OR], 4.05; 95% confidence interval [CI], 1.31-12.5; p=0.015) and operation history within 6 months (adjusted OR, 5.65; 95% CI, 1.74-18.2; p=0.004).Conclusions: The post-prostate biopsy infectious complication rate in this study was 2.2%. Person performing biopsy (non-urologists) and recent operation history were independent risk factors for infectious complications after trans-rectal prostate biopsy.
Abstract
Purpose: Recent studies have highlighted an increasing trend of infectious complications due to fluoroquinolone-resistant organisms among men undergoing transrectal prostate biopsy. This study evaluated the current incidence of infective complications after trans-rectal prostate biopsy for identification of risk factors in Korean men who received fluoroquinolone prophylaxis.Materials and Methods: A prospective, multicenter study was conducted in Korea from January to December 2015. Prostate biopsies performed with fluoroqui-nolone prophylaxis during 3 months in each center were included. A pre-biopsy questionnaire was used for identification of patient characteristics. Clinical variables including underlying disease, antibiotic prophylaxis, enema, povidone- iodine cleansing of the rectum, and infectious complications were evaluated. The primary outcome was the post-biopsy infection rate after fluoroquinolone prophylaxis. Univariable and multivariable analyses were used for identification of risk factors for infectious complications.Results: The study included 827 patients, of whom 93 patients (11.2%) reported receiving antibiotics in the previous 6 months and 2.5% had a history of prostatitis. The infectious complication rate was 2.2%. Post-biopsy sepsis was reported in 2 patients (0.2%). In multivariable analysis predictors of post-biopsy sepsis included person performing biopsy (adjusted odds ratio [OR], 4.05; 95% confidence interval [CI], 1.31-12.5; p=0.015) and operation history within 6 months (adjusted OR, 5.65; 95% CI, 1.74-18.2; p=0.004).Conclusions: The post-prostate biopsy infectious complication rate in this study was 2.2%. Person performing biopsy (non-urologists) and recent operation history were independent risk factors for infectious complications after trans-rectal prostate biopsy.
참고문헌 (28)
- Loeb S, "Systematic review of complications of prostate biopsy", Eur Urol, 64, pp.876~892 (2013)
- Drusano GL, "A population pharmacokinetic analysis of the penetration of the prostate by levofloxacin", Antimicrob Agents Chemother, 44, pp.2046~2051 (2000)
- Heidenreich A, "European Association of Urology. EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent-update 2013", Eur Urol, 65, pp.124~137 (2014)
- Loeb S, "Complications after prostate biopsy : data from SEER-Medicare", J Urol, 186, pp.1830~1834 (2011)
- Nam RK, "Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy", J Urol, 189(1 Suppl), pp.S12~S17 (2013)
- Loeb S, "Infectious complications and hospital admissions after prostate biopsy in a European randomized trial", Eur Urol, 61, pp.1110~1114 (2012)
- Ozden E, "Incidence of acute prostatitis caused by extendedspectrum beta-lactamase-producing Escherichia coli after transrectal prostate biopsy", Urology, 74, pp.119~123 (2009)
- Williamson DA, "Infectious complications following transrectal ultrasound-guided prostate biopsy : new challenges in the era of multidrug-resistant Escherichia coli", Clin Infect Dis, 57, pp.267~274 (2013)
- Levy SB, "The 2000 Garrod lecture. Factors impacting on the problem of antibiotic resistance", J Antimicrob Chemother, 49, pp.25~30 (2002)
- Hillelsohn JH, "Variability of transrectal ultrasound-guided prostate biopsy prophylactic measures", Can J Urol, 19, pp.6573~6577 (2012)
- Steensels D, "Fluoroquinolone-resistant E. coli in intestinal flora of patients undergoing transrectal ultrasoundguided prostate biopsy--should we reassess our practices for antibiotic prophylaxis?", Clin Microbiol Infect, 18, pp.575~581 (2012)
- Roberts MJ, "Baseline prevalence of antimicrobial resistance and subsequent infection following prostate biopsy using empirical or altered prophylaxis: a bias-adjusted metaanalysis", Int J Antimicrob Agents, 43, pp.301~309 (2014)
- Taylor AK, "Targeted antimicrobial prophylaxis using rectal swab cultures in men undergoing transrectal ultrasound guided prostate biopsy is associated with reduced incidence of postoperative infectious complications and cost of care", J Urol, 187, pp.1275~1279 (2012)
- Cho YH, "Antimicrobial susceptibilities of extended-spectrum betalactamase-producing Escherichia coli and Klebsiella pneumoniae in health care-associated urinary tract infection: focus on susceptibility to fosfomycin", Int Urol Nephrol, 47, pp.1059~1066 (2015)
- Wolf JS Jr, "Best practice policy statement on urologic surgery antimicrobial prophylaxis", J Urol, 179, pp.1379~1390 (2008)
- Hwang EC, "Risk factors for and prophylactic effect of povidone-iodine rectal cleansing on infectious complications after prostate biopsy: a retrospective cohort study.", Int Urol Nephrol, 47, pp.595~601 (2015)
- Park DS, "Control of infective complications of transrectal prostate biopsy", Surg Infect (Larchmt), 15, pp.431~436 (2014)
- 최중원, "Febrile Urinary Tract Infection After Prostate Biopsy and Quinolone Resistance", Investigative and Clinical Urology, 55(10), pp.660~664 (2014), 대한비뇨기과학회
- Wagenlehner FM, "GPIU investigators. Infective complications after prostate biopsy: outcome of the Global Prevalence Study of Infections in Urology (GPIU) 2010 and 2011, a prospective multinational multicentre prostate biopsy study", Eur Urol, 63, pp.521~527 (2013)
- Carignan A, "Increasing risk of infectious complications after transrectal ultrasound-guided prostate biopsies: time to reassess antimicrobial prophylaxis?", Eur Urol, 62, pp.453~459 (2012)
- Feliciano J, "The incidence of fluoroquinolone resistant infections after prostate biopsy--are fluoroquinolones still effective prophylaxis?", J Urol, 179, pp.952~955 (2008)
- 방준호, "Microbiological Characteristics of Acute Prostatitis After Transrectal Prostate Biopsy", Investigative and Clinical Urology, 54(2), pp.117~122 (2013), 대한비뇨기과학회
- Zani EL, "Antibiotic prophylaxis for transrectal prostate biopsy", Cochrane Database Syst Rev, (5), pp.CD006576~ (2011)
- Pu C, "Reducing the risk of infection for transrectal prostate biopsy with povidoneiodine : a systematic review and meta-analysis", Int Urol Nephrol, 46, pp.1691~1698 (2014)
- Abughosh Z, "A prospective randomized trial of povidone-iodine prophylactic cleansing of the rectum before transrectal ultrasound guided prostate biopsy", J Urol, 189, pp.1326~1331 (2013)
- Liss MA, "Prevalence and significance of fluoroquinolone resistant Escherichia coli in patients undergoing transrectal ultrasound guided prostate needle biopsy", J Urol, 185, pp.1283~1288 (2011)
- "Guidelines on urological infections 2015" (2015)[URL]
- Bruyere F, "Prosbiotate: a multicenter, prospective analysis of infectious complications after prostate biopsy", J Urol, 193, pp.145~150 (2015)